Mouse Polyclonal BRF2 antibody. N-terminal. Suitable for WB and reacts with Recombinant fragment - Human, Human samples. Cited in 2 publications. Immunogen corresponding to Recombinant Fragment Protein within Human BRF2 aa 1-100.
Constituents: 50% Glycerol (glycerin, glycerine)
WB | |
---|---|
Human | Tested |
Cow | Predicted |
Cynomolgus monkey | Predicted |
Recombinant fragment - Human | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant fragment - Human | Dilution info 1/500 - 1/2500 | Notes - |
Species Human | Dilution info 1/500 - 1/2500 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Cow, Cynomolgus monkey | Dilution info - | Notes - |
Select an associated product type
General activator of RNA polymerase III transcription. Factor exclusively required for RNA polymerase III transcription of genes with promoter elements upstream of the initiation sites (PubMed:11040218, PubMed:11121026, PubMed:11564744, PubMed:26638071). Contributes to the regulation of gene expression; functions as activator in the absence of oxidative stress (PubMed:26638071). Down-regulates expression of target genes in response to oxidative stress (PubMed:26638071). Overexpression protects cells against apoptosis in response to oxidative stress (PubMed:26638071).
BRFU, PRO1470, BRF2, Transcription factor IIIB 50 kDa subunit, TFIIIB50, hTFIIIB50, B-related factor 2, hBRFU, BRF-2
Mouse Polyclonal BRF2 antibody. N-terminal. Suitable for WB and reacts with Recombinant fragment - Human, Human samples. Cited in 2 publications. Immunogen corresponding to Recombinant Fragment Protein within Human BRF2 aa 1-100.
Constituents: 50% Glycerol (glycerin, glycerine)
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
The observed band size may not correspond to the predicted protein molecular weight as the immunogen (recombinant fragment) was used for the test lane.
All lanes: Western blot - Anti-BRF2 antibody - N-terminal (ab194442) at 1/2500 dilution
All lanes: BRF2 recombinant protein (immunizing peptide) at 0.2 µg
Predicted band size: 47 kDa
Observed band size: 37 kDa
All lanes: Western blot - Anti-BRF2 antibody - N-terminal (ab194442) at 1/1000 dilution
All lanes: Human ovarian cancer tissue lysate at 50 µg
Predicted band size: 47 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com